Impact of the Underlying Mutation and the Route of Vector Administration on Immune Responses to Factor IX in Gene Therapy for Hemophilia B

Immune responses to factor IX (F.IX), a major concern in gene therapy for hemophilia, were analyzed for adeno-associated viral (AAV-2) gene transfer to skeletal muscle and liver as a function of the F9 underlying mutation. Vectors identical to those recently used in clinical trials were administered...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cao, Ou, Hoffman, Brad E, Moghimi, Babak, Nayak, Sushrusha, Cooper, Mario, Zhou, Shangzhen, Ertl, Hildegund CJ, High, Katherine A, Herzog, Roland W
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2835008/
https://ncbi.nlm.nih.gov/pubmed/19603001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados